AdventHealth Polk
101 Hospital Drive, Columbus, NC · AdventHealth · · NPI 1891523718
Published prices by procedure
Cash price is what you pay without insurance. The negotiated range spans the lowest to highest rate this hospital agreed with insurers.
| Procedure | Cash price | Gross charge | Negotiated range | Payers |
|---|---|---|---|---|
| Inj. tagraxofusp-erzs 10 mcg HCPCS J9269 | not published | not published | $397.73 – $397.73 | 1 |
| Inj, taliglucerace alfa 10 u HCPCS J3060 | not published | not published | $48.33 – $48.33 | 1 |
| Inj teclistamab cqyv 0.5 mg HCPCS J9380 | not published | not published | $38.41 – $38.41 | 1 |
| Inj teplizumab mzwv 5 mcg HCPCS J9381 | not published | not published | $42.74 – $42.74 | 1 |
| Inj. teprotumumab-trbw 10 mg HCPCS J3241 | not published | not published | $409.55 – $409.55 | 1 |
| Inj testosterone cypionate HCPCS J1071 | $107.30 | $107.30 | not published | 0 |
| Inj., tildrakizumab, 1 mg HCPCS J3245 | not published | not published | $131.58 – $131.58 | 1 |
| Inj, tislelizumab-jsgr HCPCS J9329 | $32,487.79 | $32,487.79 | $64.86 – $64.86 | 1 |
| Inj tofersen intrathec 1 mg HCPCS J1304 | not published | not published | $178.12 – $178.12 | 1 |
| Inj, tofidence, 1 mg HCPCS Q5133 | not published | not published | $5.71 – $5.71 | 1 |
| Inj travoprost intra impl HCPCS J7355 | not published | not published | $219.16 – $219.16 | 1 |
| Inj., triluron, 1 mg HCPCS J7332 | not published | not published | $11.74 – $11.74 | 1 |
| Inj., triptorelin X-ray 3.75 mg HCPCS J3316 | not published | not published | $4,145.32 – $4,145.32 | 1 |
| Inj, trivisc 1 mg HCPCS J7329 | not published | not published | $3.65 – $3.65 | 1 |
| Inj, tyenne, 1 mg HCPCS Q5135 | not published | not published | $4.74 – $4.74 | 1 |
| Inj ustekinumab-aekn, 1 mg HCPCS Q9998 | not published | not published | $12.11 – $12.11 | 1 |
| Inj ustekinumab-kfce, 1 mg HCPCS Q5100 | not published | not published | $2.76 – $2.76 | 1 |
| Inj ustekinumab-stba, 1 mg HCPCS Q5099 | not published | not published | $2.60 – $2.60 | 1 |
| Inj, vancomycin hcl (mylan) HCPCS J3371 | $27.80 | $27.80 | not published | 0 |
| Inj, vancomycin hcl (xellia) HCPCS J3372 | $146.45 | $146.45 | not published | 0 |
| Inj, vegzelma, 10 mg HCPCS Q5129 | $7,940.94 | $7,940.94 | $34.27 – $34.27 | 1 |
| Inj velmanase alfa-tycv 1 mg HCPCS J0217 | not published | not published | $517.90 – $517.90 | 1 |
| Inj., vestronidase alfa-vjbk HCPCS J3397 | not published | not published | $305.10 – $305.10 | 1 |
| Inj. viltolarsen HCPCS J1427 | not published | not published | $60.91 – $60.91 | 1 |
| Inj w/fluor eval cv device CPT 36598 | $172.31 | $172.31 | not published | 0 |
| Inj. xembify, 100 mg HCPCS J1558 | not published | not published | $17.11 – $17.11 | 1 |
| Inj., yutiq, 0.01 mg HCPCS J7314 | not published | not published | $589.88 – $589.88 | 1 |
| Inj zanidatamab-hrii, 2 mg HCPCS J9276 | not published | not published | $27.82 – $27.82 | 1 |
| Inotuzumab ozogamicin 0.9 mg(0.25 mg/ml initial concentration) IV soln HCPCS J9229 | not published | not published | $3,135.65 – $3,135.65 | 1 |
| Insert cath pleura without image CPT 32556 | $3,754.59 | $3,754.59 | not published | 0 |
| Insertion catheter bladder non indwelling CPT 51701 | $457.49 | $457.49 | not published | 0 |
| Insertion catheter bladder temporary simple CPT 51702 | $357.42 | $357.42 | not published | 0 |
| Insertion nontunneled centrally inserted central venous catheter >= 5 years old CPT 36556 | $1,361.85 | $1,361.85 | not published | 0 |
| Insertion of new/replacement ppm w/transvenous electrode(s) atrial & ventricular CPT 33208 | $23,000.00 | $23,000.00 | not published | 0 |
| Insertion peripherally inserted central venous catheter (picc) without port/pump/img gud >= 5 years CPT 36569 | $3,583.23 | $3,583.23 | not published | 0 |
| Insertion picc without port or pump with imaging guidance=>5y CPT 36573 | $4,091.33 | $4,091.33 | not published | 0 |
| Insertion subcutaneous cardiac rhythm monitor CPT 33285 | $6,178.73 | $6,178.73 | not published | 0 |
| Ins/rpl prph sac/gstr npg/r CPT 64590 | $11,167.59 | $11,167.59 | not published | 0 |
| Instillation anticarcinogenic agent bladder CPT 51720 | $971.57 | $971.57 | not published | 0 |
| Instill, bupivac and meloxic HCPCS C9088 | $683.88 | $683.88 | not published | 0 |
| Insulin total CPT 83525 | $99.33 | $99.33 | not published | 0 |
| Interferon alfa-n3 inj HCPCS J9215 | not published | not published | $26.74 – $26.74 | 1 |
| Interrog evl pm/ldls pm ip CPT 93288 | $130.00 | $130.00 | not published | 0 |
| Intrinsic factor antibody CPT 86340 | $101.64 | $101.64 | not published | 0 |
| Intubation endotracheal emergency procedure CPT 31500 | $1,762.74 | $1,762.74 | not published | 0 |
| Iopamidol 250 mg iodine/ml (51 %) intravenous solution HCPCS Q9966 | $483.60 | $483.60 | not published | 0 |
| Iopamidol 300 mg iodine/ml (61 %) intravenous solution HCPCS Q9967 | $753.66 | $753.66 | not published | 0 |
| Ipilimumab 5 mg/ml intravenous solution (wrapper) HCPCS J9228 | $36,997.93 | $36,997.93 | $192.46 – $192.46 | 1 |
| Ipratropium bromide non-comp HCPCS J7644 | $8.31 | $8.31 | not published | 0 |
| Irinotecan 20 mg/ml intravenous solution (wrapper) HCPCS J9206 | $114.64 | $114.64 | $1.58 – $1.58 | 1 |
| Irinotecan liposomal 4.3 mg/ml intravenous HCPCS J9205 | $3,024.09 | $3,024.09 | $73.89 – $73.89 | 1 |
| Iron CPT 83540 | $93.98 | $93.98 | not published | 0 |
| Iron binding capacity CPT 83550 | $93.98 | $93.98 | not published | 0 |
| Iron dextran 50 mg/ml injection solution HCPCS J1750 | $95.90 | $95.90 | $32.28 – $32.28 | 1 |
| Iron sucrose 20 mg iron/ml intravenous solution (wrapper) HCPCS J1756 | $255.91 | $255.91 | $0.40 – $0.40 | 1 |
| Irradiation of blood product each unit reference CPT 86945 | $454.65 | $454.65 | not published | 0 |
| Irrigation implantable venous access device for drug delivery systems CPT 96523 | $233.21 | $233.21 | not published | 0 |
| Isatuximab-irfc 20 mg/ml intravenous solution HCPCS J9227 | $11,219.01 | $11,219.01 | $93.04 – $93.04 | 1 |
| Ivig non-lyophilized, nos HCPCS J1599 | not published | not published | $155.11 – $155.11 | 1 |
| IV infusion therapy/prophylaxis/diagnosis addl sequential infusion new drug/substance > 1 hour CPT 96367 | $773.96 | $773.96 | not published | 0 |
| IV infusion therapy/prophylaxis/diagnosis concurrent infusion CPT 96368 | $773.96 | $773.96 | not published | 0 |
| IV infusion therapy/prophylaxis/diagnosis each additional 1 hour CPT 96366 | $773.96 | $773.96 | not published | 0 |
| IV infusion therapy/prophylaxis/diagnosis initial up to 1 hour CPT 96365 | $773.96 | $773.96 | not published | 0 |
| Ivp w/wo kub w/wo tomography CPT 74400 | $1,352.40 | $1,352.40 | not published | 0 |
| Ixabepilone 15 mg intravenous solution HCPCS J9207 | not published | not published | $150.30 – $150.30 | 1 |
| Jak2 targeted sequence analysis CPT 81279 | $749.81 | $749.81 | not published | 0 |
| Ketone body(s) beta-hydroxybutyrate quantitative CPT 82010 | $118.55 | $118.55 | not published | 0 |
| Ketorolac 15 mg/ml injection (wrapper) HCPCS J1885 | $67.25 | $67.25 | not published | 0 |
| Kidney img w/bldflw sgl without rx CPT 78707 | $1,490.37 | $1,490.37 | not published | 0 |
| Kidney (Retroperitoneal) Ultrasound (complete) CPT 76770 | $1,092.00 | $1,092.00 | not published | 0 |
| Knee MRI (with and without contrast) CPT 73723 | $4,046.39 | $4,046.39 | not published | 0 |
| Knee MRI (with contrast) CPT 73722 | $3,476.76 | $3,476.76 | not published | 0 |
| Knee MRI (without contrast) CPT 73721 | $3,019.80 | $3,019.80 | not published | 0 |
| Knee X-ray CPT 73564 | $475.02 | $475.02 | not published | 0 |
| Kras gene variants exon 2 CPT 81275 | $842.00 | $842.00 | not published | 0 |
| Kyleena, 19.5 mg HCPCS J7296 | not published | not published | $1,313.16 – $1,313.16 | 1 |
| Labetalol 5 mg/ml IV (wrapper) HCPCS J1920 | $143.34 | $143.34 | not published | 0 |
| Lacosamide 200 mg/20 ml intravenous solution HCPCS C9254 | $122.49 | $122.49 | not published | 0 |
| Lactate dehydrogenase (ldh) CPT 83615 | $85.16 | $85.16 | not published | 0 |
| Lactated ringers intravenous solution HCPCS J7120 | $82.70 | $82.70 | not published | 0 |
| Lactic acid CPT 83605 | $147.74 | $147.74 | not published | 0 |
| Lanreotide 120 mg/0.5 ml subcutaneous syringe HCPCS J1930 | $26,459.86 | $26,459.86 | $37.74 – $37.74 | 1 |
| Laronidase injection HCPCS J1931 | not published | not published | $49.00 – $49.00 | 1 |
| Lead capillary CPT 83655 | $79.80 | $79.80 | not published | 0 |
| Leg Vein Ultrasound (DVT study, both legs) CPT 93970 | $1,394.61 | $1,394.61 | not published | 0 |
| Leucovorin calcium 100 mg solution for injection (1 mg rounding) HCPCS J0640 | $328.36 | $328.36 | not published | 0 |
| Leuprolide 30 mg (4 month) intramuscular syringe kit HCPCS J9217 | not published | not published | $181.19 – $181.19 | 1 |
| Leuprolide 3.75 mg intramuscular syringe kit HCPCS J1950 | not published | not published | $1,815.55 – $1,815.55 | 1 |
| Leuprolide depot cipla 7.5mg HCPCS J1954 | not published | not published | $772.07 – $772.07 | 1 |
| Leuprolide inj, camcevi, 1mg HCPCS J1952 | not published | not published | $44.47 – $44.47 | 1 |
| Levalbuterol non-comp con HCPCS J7612 | $25.79 | $25.79 | not published | 0 |
| Levetiracetam 500 mg/5 ml intravenous solution HCPCS J1953 | $122.17 | $122.17 | not published | 0 |
| Levetiracetam therapeutic drug level CPT 80177 | $135.35 | $135.35 | not published | 0 |
| Levofloxacin 250 mg/50 ml in 5 % dextrose intravenous piggyback HCPCS J1956 | $76.23 | $76.23 | not published | 0 |
| Lidocaine injection HCPCS J2001 | $33.74 | $33.74 | not published | 0 |
| Lidocaine (pf) 10 mg/ml (1 %) injection solution HCPCS J2003 | $94.83 | $94.83 | not published | 0 |
| Liletta, 52 mg HCPCS J7297 | not published | not published | $1,009.62 – $1,009.62 | 1 |
| Linezolid in 5% dextrose in water 600 mg/300 ml intravenous piggyback HCPCS J2020 | $112.13 | $112.13 | not published | 0 |
| Lipase CPT 83690 | $68.67 | $68.67 | not published | 0 |
| Lipoprotein blood quant CPT 83704 | $132.00 | $132.00 | not published | 0 |
A missing value means the hospital did not publish that price — it never means the price is zero. Real bills can add facility fees, supplies and professional fees; see our methodology.